NEW - - - SKVI Now Trading Exclusively on OTCQB
Beginning February 22, 2011 Skinvisible (SKVI) will be quoted exclusively on the new OTCQB www.otcmarkets.com with an icon reading, "OTCQB -- U.S. Registered."
This new designation is used for OTC-traded companies that are U.S. registered and reporting. The OTCQB will help investors easily identify SEC reporting companies such as Skinvisible that are current with their disclosure obligations. As of February 18, 2011, market makers that previously traded Skinvisible on the OTCBB began exclusively trading Skinvisible on the new OTCQB. We do not believe it necessary at this time to reapply for quotation on the OTCBB because of the new trend in trading on the OTCQB.
To get a SKVI quote today, click here:
IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.
Shares Outstanding Are: 132,561,325 (as of August 14, 2017)
Public Float: 68%
Insider Ownership: 32%
Fiscal Year End: December 31
November 16, 2017
New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA
September 28, 2017
Canopy Growth and Skinvisible Sign Definitive Agreement to Bring New Products to Market
July 7, 2017
Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology - Topical and Transdermal Product Licensing Opportunities Available in the US and Globally
June 6, 2017
Skinvisible Completes First Sale of DermSafe Hand Sanitizer in China - Germ Protection Now Available to Millions of People in China
February 21, 2017
Skinvisible Brings Patented Technology to the Topical and Transdermal Cannabis Industry - Invisicare Delivery System to Enhance Medical and Recreational Marijuana Product Lines
CLICK HERE TO READ ALL NEWS RELEASES
In the News:
Skinvisible featured in Drug Development & Delivery journal
Sign up for Skinvisible Inc. Updates:
Click here to join our mailing list.